全部股東
股東類型
- 機構投資者58.66%
- 創投/私募35.06%
- 公眾及其他4.28%
- 個人與內幕人士2.00%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
FMR LLC | 12.01% | 651.00 萬 | 9.17% | +497.03 萬 | 31/07/2026 |
TCG Crossover Management, LLC | 9.59% | 567.31 萬 | -- | +567.31 萬 | 31/03/2026 |
RA Capital Management, L.P. | 7.61% | 450.19 萬 | 2.37% | -90.31 萬 | 16/07/2026 |
Forbion Capital Partners B.V. | 6.96% | 411.74 萬 | 2.38% | +50.00 萬 | 31/03/2026 |
BlackRock, Inc. | 5.86% | 346.81 萬 | 4.40% | +267.33 萬 | 30/06/2026 |
VERVE CAPITAL, Inc. | 5.77% | 341.09 萬 | -- | +341.09 萬 | 30/06/2026 |
VR Management, LLC | 5.14% | 304.17 萬 | 0.12% | +109.80 萬 | 31/03/2026 |
State Street Investment Management | 4.42% | 261.63 萬 | 2.36% | +149.79 萬 | 30/06/2026 |
Frazier Life Sciences Management, LP | 4.30% | 254.39 萬 | 2.27% | +0 | 31/03/2026 |
Vanguard Capital Management, LLC | 4.03% | 238.50 萬 | 1.04% | +76.62 萬 | 30/06/2026 |
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | 3.38% | 199.99 萬 | 1.78% | +0 | 31/03/2026 |
Caligan Partners, LP | 3.25% | 192.51 萬 | 0.86% | +100.00 萬 | 31/03/2026 |
Great Point Partners, LLC | 2.96% | 175.00 萬 | 0.58% | +37.99 萬 | 31/03/2026 |
Paradigm Biocapital Advisors LP | 2.96% | 175.00 萬 | 1.56% | +0 | 31/03/2026 |
Reid Hoffman | 1.97% | 116.69 萬 | 1.04% | +0 | 21/10/2025 |
Geode Capital Management, LLC | 1.80% | 106.25 萬 | 1.16% | +71.99 萬 | 30/06/2026 |
Nextbio Capital Management LP | 1.69% | 100.00 萬 | 0.89% | +0 | 31/03/2026 |
Logos Global Management, L.P. | 1.27% | 75.00 萬 | 1.01% | +65.00 萬 | 31/03/2026 |
Rosalind Advisors, Inc. | 1.18% | 70.00 萬 | -- | +70.00 萬 | 31/03/2026 |
Nan Fung Trinity (HK) Limited | 1.09% | 64.66 萬 | -- | +64.66 萬 | 30/06/2026 |